Single-stock moves reflected event-driven trading. Vanda Pharmaceuticals surged after the US FDA approved its motion-sickness treatment tradipitant. Axsome Therapeutics jumped...
On Dec. 30, 2025, investors weighed weaker delivery guidance, analyst pushback, and supply-chain risks against Tesla’s AI ambitions.Today's Change(-1.13%) $-5.21Current...